Table 2.
Levels of statistical significance during the comparison of different parameters and groups.
| NAN-LA versus NAN-HA | NAN-LA versus AN-LA | NAN-HA versus AN-HA | AN-LA versus AN-HA | |
|---|---|---|---|---|
| Body Weight | ||||
| Baseline | 0.467 | <0.001 | 0.075 | 0.265 |
| 3 months | 0.003 | 0.063 | 0.420 | 0.009 |
| Body weight gain (%) | 0.002 | <0.001 | 0.020 | 0.098 |
| Ovarian weight (g) | <0.001 | 0.027 | 0.716 | <0.001 |
| Glucose (mg/dL) | 0.013 | 0.270 | 0.006 | 0.049 |
| Insulin (μIU/mL) | 0.001 | 0.243 | 0.008 | 0.007 |
| Testosterone (ng/mL) | <0.001 | 0.427 | 0.435 | 0.001 |
| E2 (pmol/L) | <0.001 | 0.295 | 0.429 | 0.046 |
| PGR (pmol/L) | <0.001 | <0.001 | 0.001 | <0.001 |
| AGEs (U/mL) | <0.001 | 0.228 | 0.892 | <0.001 |
| GLO-I activity (mU/mg protein) | 0.006 | <0.001 | 0.001 | 0.760 |
| AGE immunostaining granulosa | <0.001 | 0.630 | 0.619 | 0.001 |
Data were considered significant at p ≤ 0.05.